Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa

被引:0
|
作者
Schoffelen, A. [1 ]
Wensing, A. [2 ]
Tempelman, H. [3 ]
Geelen, S. [4 ]
Hoepelman, A. [1 ]
Barth, R. [1 ]
机构
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands
[3] Ndlovu Care Grp, Elandsdoorn, Limpopo, South Africa
[4] Univ Med Ctr Utrecht, Dept Pediat Infect Dis, Utrecht, Netherlands
关键词
D O I
10.7448/IAS.15.6.18254
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:154 / 155
页数:2
相关论文
共 50 条
  • [41] Sustained immunologic response while continuing on antiretroviral therapy despite virological failure
    Dionisio, D
    Vivarelli, A
    Zazzi, M
    Esperti, F
    Fabbri, C
    Giorni, M
    Menichini, B
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 5 - 7
  • [42] High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa
    Garone, D. B.
    Conradie, K.
    Patten, G.
    Cornell, M.
    Goemaere, E.
    Kunene, J.
    Kerschberger, B.
    Ford, N.
    Boulle, A.
    van Cutsem, G.
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2013, 14 (04) : 166 - 169
  • [43] Factors predictive of virological failure on atazanavir in 310 HIV-infected patients
    Lescure, Francois-Xavier
    Poirier, Jean-Marie
    Meynard, Jean-Luc
    Guiard-Schmid, Jean-Baptiste
    Zouai, Ouahiba
    Bonnard, Philippe
    Slama, Laurence
    Amiel, Corinne
    Girard, Pierre-Marie
    Pialoux, Gilles
    AIDS, 2010, 24 (10) : 1593 - 1595
  • [44] New therapeutic options in protracted hiv-infected patients with virological failure
    Cuerda, Victor Julian Moreno
    Garcia, Rafael Rubio
    Conejo, Montserrat Morales
    MEDICINA CLINICA, 2008, 130 (02): : 66 - 70
  • [45] Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients
    Bastard, Mathieu
    Pinoges, Loretxu
    Balkan, Suna
    Szumilin, Elisabeth
    Ferreyra, Cecilia
    Pujades-Rodriguez, Mar
    PLOS ONE, 2012, 7 (11):
  • [46] Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure
    Mwasakifwa, Gwamaka Eliudi
    Amin, Janaki
    Kelleher, Anthony
    Boyd, Mark A.
    AIDS, 2021, 35 (14) : 2289 - 2298
  • [47] Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan
    Shafiq, Muhammad
    Zafar, Sana
    Ahmad, Aftab
    Kazmi, Abeer
    Fatima, Alina
    Mujahid, Tanvir Ahmed
    Qazi, Rizwan
    Akhter, Nasim
    Shahzad, Amir
    Rehman, Saif Ur
    Shereen, Muhammad Adnan
    Hyder, Muhammad Zeeshan
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [48] Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients -: Reply
    Fätkenheuer, G
    Rockstroh, J
    Salzberger, B
    AIDS, 1998, 12 (11) : 1402 - 1403
  • [49] Factors associated with virological response to raltegravir in experienced HIV-infected patients
    Marcelin, A. G.
    Delaugerre, C.
    Flandre, P.
    Descamps, D.
    Morand-Joubert, L.
    Amiel, C.
    Ferre, V.
    Izopet, J.
    Masquelier, B.
    Calvez, V.
    ANTIVIRAL THERAPY, 2011, 16 : A74 - A74
  • [50] Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
    Paton, Nicholas I.
    Kityo, Cissy
    Hoppe, Anne
    Reid, Andrew
    Kambugu, Andrew
    Lugemwa, Abbas
    van Oosterhout, Joep J.
    Kiconco, Mary
    Siika, Abraham
    Mwebaze, Raymond
    Abwola, Mary
    Abongomera, George
    Mweemba, Aggrey
    Alima, Hillary
    Atwongyeire, Dickens
    Nyirenda, Rose
    Boles, Justine
    Thompson, Jennifer
    Tumukunde, Dinah
    Chidziva, Ennie
    Mambule, Ivan
    Arribas, Jose R.
    Easterbrook, Philippa J.
    Hakim, James
    Walker, A. Sarah
    Mugyenyi, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03): : 234 - 247